Association of caffeine and related analytes with resistance to Parkinson’s disease among LRRK2 mutation carriers: a metabolomic study

Crotty, Grace F, Maciuca, Romeo, Macklin, Eric A, Wang, Junhua, Montalban, Manuel, Davis, Sonnet S., Alkabsh, Jamal I, Bakshi, Rachit, Chen, Xiqun, Ascherio, Alberto, Astarita, Giuseppe, Huntwork-Rodriguez, Sarah, Schwarzschild, Michael A

Open source

DOI
10.5061/dryad.nzs7h44pj
Published
2021
Container
Not recorded
Publisher
Dryad
Open access
yes

Credibility signals

limited evidence Score 47/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.5061/dryad.nzs7h44pj,
  title = {Association of caffeine and related analytes with resistance to Parkinson’s disease among LRRK2 mutation carriers: a metabolomic study},
  author = {Crotty, Grace F and Maciuca, Romeo and Macklin, Eric A and Wang, Junhua and Montalban, Manuel and Davis, Sonnet S. and Alkabsh, Jamal I and Bakshi, Rachit and Chen, Xiqun and Ascherio, Alberto and Astarita, Giuseppe and Huntwork-Rodriguez, Sarah and Schwarzschild, Michael A},
  year = {2021},
  doi = {10.5061/dryad.nzs7h44pj},
  url = {https://doi.org/10.5061/dryad.nzs7h44pj}
}

RIS

TY  - JOUR
TI  - Association of caffeine and related analytes with resistance to Parkinson’s disease among LRRK2 mutation carriers: a metabolomic study
AU  - Crotty, Grace F
AU  - Maciuca, Romeo
AU  - Macklin, Eric A
AU  - Wang, Junhua
AU  - Montalban, Manuel
AU  - Davis, Sonnet S.
AU  - Alkabsh, Jamal I
AU  - Bakshi, Rachit
AU  - Chen, Xiqun
AU  - Ascherio, Alberto
AU  - Astarita, Giuseppe
AU  - Huntwork-Rodriguez, Sarah
AU  - Schwarzschild, Michael A
PY  - 2021
DO  - 10.5061/dryad.nzs7h44pj
UR  - https://doi.org/10.5061/dryad.nzs7h44pj
ER  - 

APA

F, C. G., Romeo, M., A, M. E., Junhua, W., Manuel, M., S., D. S., I, A. J., Rachit, B., Xiqun, C., Alberto, A., Giuseppe, A., Sarah, H., & A, S. M. (2021). Association of caffeine and related analytes with resistance to Parkinson’s disease among LRRK2 mutation carriers: a metabolomic study. https://doi.org/10.5061/dryad.nzs7h44pj

Source records